Andrea Coravos, Angel Investor

Andrea (Andy) Coravos is the Co-Founder and former CEO of HumanFirst, a company dedicated to advancing patient-centered research through precision measurement tools. Under their leadership, HumanFirst grew into a recognized leader in digital health and clinical data science before being acquired by ICON plc in 2024, where Coravos served as Managing Director to integrate the company’s technology into ICON’s global research platform. Before founding HumanFirst, Coravos collaborated with the Harvard-MIT Center for Regulatory Science, focusing on innovation at the intersection of healthcare, data, and policy. Their work continues to emphasize how technology can improve access, outcomes, and trust in biomedical research. Coravos is also an active angel investor with over a dozen investments across healthtech, biotech, and AI sectors. Their portfolio includes companies such as Blue, Loyal, Morf Health, Legacy, and Infinity AI, with rounds ranging from pre-seed to Series B. Their investments focus on technologies that accelerate human health, precision medicine, and ethical innovation in life sciences.